Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Glucose tolerance impaired
ADR ID BADD_A01859
ADR Hierarchy
05      Endocrine disorders
05.06      Glucose metabolism disorders (incl diabetes mellitus)
05.06.02      Hyperglycaemic conditions NEC
05.06.02.001      Glucose tolerance impaired
14      Metabolism and nutrition disorders
14.06      Glucose metabolism disorders (incl diabetes mellitus)
14.06.02      Hyperglycaemic conditions NEC
14.06.02.001      Glucose tolerance impaired
Description A pathological state in which BLOOD GLUCOSE level is less than approximately 140 mg/100 ml of PLASMA at fasting, and above approximately 200 mg/100 ml plasma at 30-, 60-, or 90-minute during a GLUCOSE TOLERANCE TEST. This condition is seen frequently in DIABETES MELLITUS, but also occurs with other diseases and MALNUTRITION. [MeSH]
MedDRA Code 10018429
MeSH ID D018149; D011236
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Abnormal glucose tolerance | Borderline diabetes | Chemical diabetes | Glucose tolerance abnormal | Glucose tolerance impaired | Latent diabetes | Pre-diabetes | Pre-diabetic | Subclinical diabetes | Glucose intolerance | Prediabetes | Glucose Intolerance | Glucose Intolerances | Intolerance, Glucose | Intolerances, Glucose | Impaired Glucose Tolerance | Glucose Tolerance, Impaired | Glucose Tolerances, Impaired | Impaired Glucose Tolerances | Tolerance, Impaired Glucose | Tolerances, Impaired Glucose
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02173Testosterone propionate--
BADD_D02174Testosterone undecanoate--
BADD_D02236Tofacitinib0.003400%
BADD_D02271Triamcinolone--
BADD_D02272Triamcinolone acetonide--
BADD_D02274Triamcinolone hexacetonide--
BADD_D02331Valsartan0.000143%
BADD_D02346Venlafaxine0.000032%
BADD_D02398Zuclopenthixol--
BADD_D02412Octreotide--
BADD_D02436Atorvastatin0.000077%
BADD_D02580Ozanimod0.000241%
The 3th Page    First    Pre   3    Total 3 Pages